Literature DB >> 29689118

Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Benoit Callendret, Jort Vellinga, Kerstin Wunderlich, Ariane Rodriguez, Robin Steigerwald, Ulrike Dirmeier, Cedric Cheminay, Ariane Volkmann, Trevor Brasel, Ricardo Carrion, Luis D Giavedoni, Jean L Patterson, Chad E Mire, Thomas W Geisbert, Jay W Hooper, Mo Weijtens, Jutta Hartkoorn-Pasma, Jerome Custers, Maria Grazia Pau, Hanneke Schuitemaker, Roland Zahn.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0192312.].

Entities:  

Year:  2018        PMID： 29689118      PMCID： PMC5916865          DOI： 10.1371/journal.pone.0196546

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The following information is missing from the Funding section: This work was supported by the National Institute of Allergy and Infectious Diseases (grant no. HHSN272200800056C to BC).
  1 in total

1.  A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates.

Authors:  Benoit Callendret; Jort Vellinga; Kerstin Wunderlich; Ariane Rodriguez; Robin Steigerwald; Ulrike Dirmeier; Cedric Cheminay; Ariane Volkmann; Trevor Brasel; Ricardo Carrion; Luis D Giavedoni; Jean L Patterson; Chad E Mire; Thomas W Geisbert; Jay W Hooper; Mo Weijtens; Jutta Hartkoorn-Pasma; Jerome Custers; Maria Grazia Pau; Hanneke Schuitemaker; Roland Zahn
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240
  1 in total
  1 in total

1.  Multimerization of Ebola GPΔmucin on protein nanoparticle vaccines has minimal effect on elicitation of neutralizing antibodies.

Authors:  Abigail E Powell; Duo Xu; Gillie A Roth; Kaiming Zhang; Wah Chiu; Eric A Appel; Peter S Kim
Journal:  Front Immunol       Date:  2022-08-24       Impact factor: 8.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.